Diagnostic Role of Tumor Markers for Hepatocellular Carcinoma in Liver Transplantation Candidates: An Analysis Using the Korean Organ Transplantation Registry Database

Woo-Hyoung Kang; Shin Hwang; Jong Man Kim; Kwang-Woong Lee; Dong Jin Joo; Young Kyoung You; Je Ho Ryu; Bong-Wan Kim; Donglak Choi; Dong-Sik Kim; Yang Won Nah

doi:10.12659/AOT.936937

13 September 2022 : Original article

Diagnostic Role of Tumor Markers for Hepatocellular Carcinoma in Liver Transplantation Candidates: An Analysis Using the Korean Organ Transplantation Registry Database

Woo-Hyoung Kang

^1ABCDE, Shin Hwang^1ABCDEFG*, Jong Man Kim

^2BCE, Kwang-Woong Lee^3BDE, Dong Jin Joo^4BDE, Young Kyoung You^5BDE, Je Ho Ryu^6BCE, Bong-Wan Kim^7BDE, Donglak Choi^8BDE, Dong-Sik Kim

^9BDE, Yang Won Nah^10BDE

DOI: 10.12659/AOT.936937

Ann Transplant 2022; 27:e936937

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 3 Comparison of alpha-fetoprotein (AFP; A) and protein induced by vitamin K absence or antagonist-II (PIVKA-II; B) levels according to viable and no hepatocellular carcinoma (HCC) in patients with hepatitis B virus (HBV)-associated liver cirrhosis. Bars indicate 25–75 percentiles. C) Receiver operating characteristic curve analysis of AFP and PIVKA-II for diagnosis of HCC. AUC indicates the area under the curve.

Back to the Article

Diagnostic Role of Tumor Markers for Hepatocellular Carcinoma in Liver Transplantation Candidates: An Analysis Using the Korean Organ Transplantation Registry Database

Your Privacy